CoChat

SPECT and PET imaging in Alzheimer’s disease

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia. Beta-amyloid (Aβ) deposition and neurofibrillary tangles (NFTs) of abnormal hyperphosphorylated tau protein are the pathological hallmarks of the disease, accompanied by other pathological processes such as microglia activation. Functional and molecular nuclear medicine imaging with single-photon emission computed tomography (SPECT) and positron emission tomography (PET) techniques provides valuable information about the underlying pathological processes, many years before the appearance of clinical symptoms. Nuclear neuroimaging in AD has made great progress in the past two decades and has extended beyond the traditional role of brain perfusion and glucose metabolism evaluation. Intense efforts in radiopharmaceuticals research have led to the development of various probes able to detect Aβ deposits, tau protein accumulation, microglia activation and neuroinflammation. As a result, SPECT and PET have proposed to serve as biomarkers in recently revised diagnostic clinical criteria for the early diagnosis of AD and the prediction of progression to AD in mild cognitive impairment (MCI) subjects.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12149-018-1292-6

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 110 references

Cited by

See all 194

Metadata

Authors
Valotassiou, V., Malamitsi, J., Papatriantafyllou, J., Dardiotis, E., Tsougos, I., Psimadas, D., Alexiou, S., Hadjigeorgiou, G., & Georgoulias, P.
Affiliations
  • University Hospital of Larissa (GR)
  • National and Kapodistrian University of Athens (GR)
  • University of Cyprus (CY)
Corresponding author
Valotassiou, Varvara
Venue
Annals of Nuclear Medicine
Published
2018-08-20
Volume
32
Issue
9
Pages
583-593
ISSN
  • 0914-7187 (ISSN-L)
  • 1864-6433
OpenAlex
W2888363961
Cited by
169
References
110
Citations by year
2026: 8 · 2025: 27 · 2024: 32 · 2023: 31 · 2022: 22 · 2021: 27 · 2020: 14 · 2019: 8
FWCI
1.89
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Annals of Nuclear Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
Alzheimer's disease, single photon emission computed tomography, positron emission tomography, amyloid-beta imaging, neurofibrillary tangles, microglial activation, neuroinflammation, radiopharmaceuticals, early diagnosis, mild cognitive impairment, biomarkers, cerebral perfusion, glucose metabolism
MeSH terms
Alzheimer Disease, Brain, Humans, Tomography, Emission-Computed, Single-Photon, tau Proteins, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SPECT and PET imaging in Alzheimer’s disease. https://app.cochat.ai/papers/10.1007/s12149-018-1292-6
The paper
Valotassiou, V., Malamitsi, J., Papatriantafyllou, J., Dardiotis, E., Tsougos, I., Psimadas, D., Alexiou, S., Hadjigeorgiou, G., & Georgoulias, P. (2018). SPECT and PET imaging in Alzheimer’s disease. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-018-1292-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.